Showing results (1621-1630 of 4,056) with videos related to
Sort By:
Pageof 406
Translational Cancer Research|January 9, 2026
Sarcopenia-driven gene model as a clinically actionable prognostic signature for head and neck squamous cell carcinomaKun Gao, Zheran Liu, Meng Dou, et al.Translational Cancer Research|January 9, 2026
Preoperative prediction of breast cancer Ki-67 status via multimodal ultrasound-clinical nomogram: a single-center studyXiao-Kai Lu, Nian-Qiu Liu, Yi-Hang Li, et al.Translational Cancer Research|January 9, 2026
Prognosis and chemotherapy efficacy in small-tumor breast cancer with different immune subtypes: a SEER-based studyHong Mei Wang, Yue Hui Zhou, Gu Bin Lin, et al.Translational Cancer Research|January 9, 2026
Stratifying prognosis in stage III colorectal cancer patients: the role of tumor deposits and lymph node ratioXiaoqiang Wang, Xufeng Shu, Chendong Yuan, et al.Translational Cancer Research|January 9, 2026
Molecular characterization and prognostic modeling of liquid-liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysisXinyu Huang, Liang Xiong, Jiaxing Zeng, et al.Translational Cancer Research|January 9, 2026
Transfer RNA-derived fragment tRF-28-P4R8YP9LOND5 as a novel serum biomarker for gastric cancer: diagnostic efficacy and clinicopathological correlationsFei Gu, Yuan Yuan, Hui Cong, et al.Translational Cancer Research|January 9, 2026
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscapeAmanda Herrmann, Christopher Grant, Lyudmila BazhenovaTranslational Cancer Research|January 9, 2026
LASSO-based nomograms predict early death in small cell lung cancer (SCLC) patients with brain metastasisXiaohao Liu, Long Wang, Linkuan Huangfu, et al.Translational Cancer Research|January 9, 2026
A novel prognostic and immune-related biomarker KCNC3 in colorectal cancer: a pan-cancer analysisKun Xia, Hong-Chao Zhu, Fang-Ye Lai, et al.Translational Cancer Research|January 9, 2026
Bufalin: a potential drug for regulating EGFR-TKIs resistance in lung cancer via the EGFR-PI3K/Akt-mTOR signalingYueqin Bai, Yabin Gong, Ruifang Cui, et al.Pageof 406